Post Stroke clinical trials

Explore recruiting post stroke clinical trials.

Recruiting post stroke studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Post Stroke trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Maintenance Therapy of the Effects of Donepezil-iGaLa Combined Therapy in Post-Stroke Chronic Aphasia: Identification of Predictive Biomarkers of Efficacy.

Spain

Therapeutic confirmatory (Phase III) EU CTIS Study details

APEDOC: The role of peripheral afferents in modulating post-stroke central pain

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Reduction of SystemiC Inflammation after ischemic stroke by intravenous DNase administration (ReSCInD)

Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

Comparative study of the mechanism of action of Dry Needling and Botulinum Toxin type A as a treatment for lower limb post-stroke spasticity: a proof of concept controlled trial

Spain, Belgium

Therapeutic exploratory (Phase II) EU CTIS Study details

Pharmacokinetic Study of Single and Multiple Dose of PKL-021 Administered Orally to Healthy Subjects

Czechia

Human Pharmacology (Phase I)- Other EU CTIS Study details

A Multicentre, Interventional, Post-marketing, Randomised, Double-blind, Crossover Study to Evaluate the Clinical Safety and Efficacy of AbobotulinumtoxinA (Dysport®) in Comparison with OnabotulinumtoxinA (Botox®) when Treating Adults with Upper Limb Spasticity

France

Therapeutic use (Phase IV) EU CTIS Study details

Post Stroke trials by city

Post Stroke in Toronto Post Stroke in Vancouver Post Stroke in Montreal Post Stroke in Calgary Post Stroke in Edmonton Post Stroke in Ottawa Post Stroke in Winnipeg Post Stroke in Quebec City Post Stroke in Hamilton Post Stroke in Kitchener Post Stroke in London Post Stroke in Halifax Post Stroke in New York Post Stroke in Los Angeles Post Stroke in Chicago Post Stroke in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease